CrapoRO, MorrisAH, GardnerRM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 1981;123(6):659–664.
WorsleyDF, PalevskyHI, AlaviA.Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med. 1994;35(5):793–796.
4.
FarberHW, FallsR, GlauserFL. Transient pulmonary hypertension from the intravenous injection of crushed, suspended pentazocine tablets. Chest. 1981;80(2):178–182.
5.
MetteSA, PalevskyHI, PietraG, WilliamsTM, BruderE, PrestipinoAJ, et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis. 1992;145(5):1196–1200.
6.
BellocqA, MilleronB.[Pulmonary hypertension: a rare complica- tion of hepatic cirrhosis.]Rev Pneumol Clin. 1993;49(4):194–196.
7.
MorseJH, JonesAC, BarstRJ, HodgeSE, WilhelmsenKC, NygaardTG. Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. Circulation. 1997;95(12):2603–2606.
D'AlonzoGE, BarstRJ, AyresSM, BergofskyEH, BrundageBH, DetreKM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115(5):343–349.
10.
DantzkerDR. Primary pulmonary hypertension: the American ex- perience. Chest. 1994;105(2 Suppl):26S–28S.
11.
ThurmCA, WigleyFM, DoleWP, WiseRA. Failure of vasodilator therapy to alter pulmonary diffusing capacity in systemic sclerosis. Am J Med. 1991;90(5):547–552.
